首页> 美国卫生研究院文献>Gynecology and Minimally Invasive Therapy >Laparoscopy and Computed Tomography Imaging in Advanced Ovarian Tumors: A Roadmap for Prediction of Optimal Cytoreductive Surgery
【2h】

Laparoscopy and Computed Tomography Imaging in Advanced Ovarian Tumors: A Roadmap for Prediction of Optimal Cytoreductive Surgery

机译:腹腔镜和计算机断层摄影术在晚期卵巢肿瘤中的应用:预测最佳细胞还原手术的路线图

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction:Comprehensive staging laparotomy and cytoreductive surgery followed by chemotherapy has been the standard of care in advanced ovarian cancer. Neoadjuvant chemotherapy is an alternative in inoperable advanced cases. To select patients amenable for successful cytoreduction, major determinants including CT imaging and laparoscopy could be of value. There is no general accepted model for selection and reproducibility of techniques are a major challenge due to different clinical practice and complexity of scoring systems. Some lesions as small size (<5 mm) peritoneal deposits and mesenteric affection are hard to see on CT so, complementary laparoscopy may play a role in the preoperative assessment. The aim of this study was evaluation of the role of laparoscopy in advanced ovarian tumors for prediction of optimal cytoreductive surgery in relation to CT and surgical peritoneal carcinomatosis index (PCI).
机译:简介:全面分期剖腹术和细胞减灭术后进行化学治疗已成为晚期卵巢癌的治疗标准。新辅助化疗是无法手术的晚期病例的替代方法。为了选择适合于成功的细胞减少的患者,包括CT成像和腹腔镜检查在内的主要决定因素可能是有价值的。由于不同的临床实践和评分系统的复杂性,目前尚无普遍接受的模型选择和技术可重复性成为主要挑战。在CT上很难看到一些病灶,如小尺寸(<5 mm)的腹膜沉积物和肠系膜病变,因此,腹腔镜辅助检查可能在术前评估中起作用。这项研究的目的是评估腹腔镜在晚期卵巢肿瘤中的作用,以预测与CT和外科腹膜癌变指数(PCI)相关的最佳细胞减灭术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号